Longitude Capital Partners Iii, LLC
10% Owner
Avg. Two Year Performance
124% Avg. Purchase Return
50% Compound
No Sale Track Record
Holdings: 3.2M shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions